Marquette Asset Management »

Atea Pharmaceuticals shares owned by Marquette Asset Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Marquette Asset Management from 13F filings

Historical chart of Marquette Asset Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Marquette Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Marquette Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $144k 47k 3.05
2023-09-30 $75k 25k 3.00
2023-06-30 $93k 25k 3.74
2023-03-31 $83k 25k 3.35

More positions owned by Marquette Asset Management

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Schwab Strategic Tr Us Dividend Eq (SCHD)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Us Aggbd Et (AGG)
Victory Portfolios Ii Short Trm Bd Etf (USTB)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Ser Tr S&p Kensho New (KOMP)
Invesco Exchange Traded Fd T S&p500 Pur Gwt (RPG)
Dimensional Etf Trust Emerging Mkts Va (DFEV)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Rus 1000 Val Etf (IWD)
First Tr Dow Jones Select Mi Com Shs Annual (FDM)

View all positions for Marquette Asset Management

Top funds holding Atea Pharmaceuticals

EcoR1 Capital
BML Capital Management
Vanguard Group
Tang Capital Management
Federated Investors
Charles Schwab Investment Management
Jacobs Levy Equity Management
Newtyn Management
Banque Pictet & Cie Sa
Two Sigma Advisers
CM Management
Bank of America Corporation
Bank of New York Mellon
Goldman Sachs Group
Barclays

View all funds holding Atea Pharmaceuticals